Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
International Journal of Environmental Research and Public Health|April 30, 2021
Measuring the Impact of Genetic and Environmental Risk and Protective Factors on Speech, Language, and Communication Development-Evidence from AustraliaPaula Cronin, Stephen Goodall
Health Policy (Amsterdam, Netherlands)|October 22, 2010
Considering consumer choice in the economic evaluation of mandatory health programmes: a reviewBonny Parkinson, Stephen Goodall
British Journal of Clinical Pharmacology|May 3, 2020
Cost-effectiveness and financial risks associated with immune checkpoint inhibitor therapyHansoo Kim, Danny Liew, Stephen Goodall
International Journal of Technology Assessment in Health Care|June 15, 2022
Current Issues in Health Technology Assessment of Cancer Therapies: A Survey of Stakeholders and Opinion Leaders in AustraliaHansoo Kim, Danny Liew, Stephen Goodall
Applied Health Economics and Health Policy|March 16, 2013
Measuring the loss of consumer choice in mandatory health programmes using discrete choice experimentsBonny Parkinson, Stephen Goodall, Richard Norman
Value in Health Regional Issues|January 11, 2021
Health Technology Assessment in Australia: The Pharmaceutical Benefits Advisory Committee and Medical Services Advisory CommitteeHansoo Kim, Joshua Byrnes, Stephen Goodall, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
Health Technology Assessment Challenges in Oncology: 20 Years of Value in HealthHansoo Kim, Stephen Goodall, Danny Liew
The Journal of Nutrition|December 11, 2012
The cost-effectiveness of mandatory folic acid fortification in AustraliaViktoria Rabovskaja, Bonny Parkinson, Stephen Goodall
Pageof 11